Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Patent
1998-08-25
2000-07-04
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
424 97, 424 98, 436172, 436800, A61B 1000, G01N 2176
Patent
active
060834870
ABSTRACT:
A method for differentiating between normal tissue and tumor tissue within a tissue field. The method includes the application of a photosensitizer solution to the tissue field and the subsequent illumination and measurement of fluorescent intensity across the tissue field. The measurement of relative fluorescent intensity across the tissue field provides information relating to the existence or nonexistence of tumor tissue. Solution concentrations of methylene blue and or toluidene blue are utilized to provide the greatest differentiability between normal tissue and tumor tissue within the tissue field.
REFERENCES:
patent: 5372801 (1994-12-01), Malmros et al.
Gill, W.B. et al., Selective Surface Staining of Bladder Tumors by Intravesical Methylene Blue with Enhanced Endoscopic Identification, Cancer, 53, 2724-2727, 1984.
Peng, Q. et al., Biodistribution of a methylene blue derivative in tumor and normal tissues of rats, Jour. Photochem. Photobiol, B: Biol., 20, 63-71, 1993.
Advanced Photodynamic Technologies, Inc.
Dees Jos,e G.
Hartley Michael G.
LandOfFree
Methylene blue and toluidene blue mediated fluorescence diagnosi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methylene blue and toluidene blue mediated fluorescence diagnosi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylene blue and toluidene blue mediated fluorescence diagnosi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1483275